BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, timing, size, and terms.
Net proceeds will be used to purchase gold bullion, working capital, and general corporate purposes.
Proposed Public Offering
BioSig intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
Net proceeds will be utilized for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
SEC Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
- BioSig Technologies is merging with Streamex Exchange Corporation.
- The company aims to bring the gold market on chain with gold tokenization technology through Streamex.
Interested parties should read the preliminary prospectus supplement and base prospectus before investing in the offering.